Abha Power and Steel IPo
smelistedAbout the company
Abha Power and Steel is a key player in the iron and steel foundry industry, based in Bilaspur, Chhattisgarh. Established in 2004, the company specializes in custom castings across grades like mild steel, SGCI, manganese steel, and high alloys. It produces castings from 0.5 kg to 6 tonnes for industries like railways, steel, cement, mining, and power. Operating two advanced foundries across 319,200 sq. ft., it exports to the UAE, Germany, Canada, and Italy. With a 2.99 MW solar plant and strategic location, it focuses on sustainability and cost efficiency, serving loyal domestic and global clients.
GMP trend (Grey Market Premium by date)
| Date | GMP (₹) | Est. Listing | Change |
|---|---|---|---|
| 25 Aug | ₹0 | ₹75 | 0 |
| 24 Aug | ₹0 | ₹75 | 0 |
| 23 Aug | ₹0 | ₹75 | 0 |
| 22 Aug | ₹0 | ₹75 | 0 |
| 21 Aug | ₹0 | ₹75 | 0 |
| 20 Aug | ₹0 | ₹75 | 0 |
| 19 Aug | ₹0 | ₹75 | 0 |
| 18 Aug | ₹0 | ₹75 | 0 |
Strengths
- Experienced Healthcare Management: Led by a doctor-driven management team with experience in hospital operations and healthcare services.
- Established Hospital Presence: The company has an established healthcare business with a track record of operating and financial growth.
- Diversified Specialties: Operations across multiple clinical specialties help reduce dependence on a single healthcare segment.
- Experienced Medical Team: The company focuses on attracting and retaining experienced doctors and clinical professionals to support quality patient care.
Risks
- High Debt Levels: The company has significant borrowings, which can increase financial costs and pressure cash flows.
- Intense Competition: Competition from established hospitals and healthcare providers could affect patient volumes, pricing and profitability.
- Doctor Dependence: The business depends heavily on experienced doctors and medical professionals, making retention of key clinicians important.
- Regulatory Risk: Hospitals are subject to extensive healthcare, safety, medical and regulatory requirements, and changes in regulations could increase costs.
- Patient Concentration Risk: Changes in patient volumes, treatment preferences or the ability of patients to pay could affect revenue and cash flows.
Financial performance (₹ Cr)
IPO Roadmap / Timeline
IPO Opens
Completed27 Nov 2024Bidding starts for all investor categories
IPO Closes
Completed29 Nov 2024Last day to place your bid
Basis of Allotment
Completed02 Dec 2024Share allotment finalised
Refund Initiation
Completed03 Dec 2024Refunds credited for non-allottees
Credit to Demat
Completed03 Dec 2024Allotted shares credited to demat account
Listing on Exchange
Completed04 Dec 2024Shares list on NSE / BSE
Post-close dates are indicative as per SEBI T+3 listing framework and may change per registrar updates.
Lot size & minimum investment
| Investor Type | Min Lots | Min Shares | Min Amount | Max Lots | Max Amount | Notes |
|---|---|---|---|---|---|---|
| Retail / Individual | 1 | 1600 | ₹120,000 | 1 | ₹120,000 | 1 lot only |
| HNI | 2 | 3200 | ₹240,000 | 2 | ₹240,000 | Min 2 lots |
Shares reserved per category & allotment probability
| Category | Reservation | Shares Offered | Amount (₹ Cr) | Shares Bid | Subscribed | Allotment % |
|---|---|---|---|---|---|---|
| QIB | 50% | 2,533,334 | 19 | 0 | 0.00x | 100% |
| NII | 15% | 760,000 | 5.7 | 0 | 0.00x | 100% |
| Retail | 35% | 1,773,333 | 13.3 | 0 | 0.00x | 100% |
Retail is a lottery-based allotment when oversubscribed; QIB/NII get pro-rata. Probability ≈ 1 / subscription times (100% if under-subscribed).
